Trader consensus heavily favors an 85–90 cumulative influenza-associated hospitalization rate per 100,000 population for Week 22 of the 2025–2026 season, reflecting CDC FluSurv-NET data showing activity has declined sharply since the winter peak. Weekly rates fell below 2 per 100,000 by March, with minimal new laboratory-confirmed admissions expected in late May and early June when influenza transmission typically reaches baseline levels. Historical patterns confirm that post-peak additions to cumulative totals remain small once surveillance indicators drop, supporting the narrow range around the current trajectory near 82. An atypical late-season resurgence or reporting delays could nudge the final figure outside 85–90, though such shifts remain unlikely given ongoing monitoring.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoFlu Hospitalization Rate Week 22, 2026?
Flu Hospitalization Rate Week 22, 2026?
85–90 95%
90–95 3.5%
100+ 3.3%
<80 3.0%
NUEVO
NUEVO
12 jun 2026
<80
3%
80–85
1%
85–90
95%
90–95
3%
95–100
2%
100+
3%
85–90 95%
90–95 3.5%
100+ 3.3%
<80 3.0%
NUEVO
NUEVO
12 jun 2026
<80
$121 Vol.
3%
80–85
$124 Vol.
1%
85–90
$385 Vol.
95%
90–95
$104 Vol.
3%
95–100
$114 Vol.
2%
100+
$104 Vol.
3%
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Trader consensus heavily favors an 85–90 cumulative influenza-associated hospitalization rate per 100,000 population for Week 22 of the 2025–2026 season, reflecting CDC FluSurv-NET data showing activity has declined sharply since the winter peak. Weekly rates fell below 2 per 100,000 by March, with minimal new laboratory-confirmed admissions expected in late May and early June when influenza transmission typically reaches baseline levels. Historical patterns confirm that post-peak additions to cumulative totals remain small once surveillance indicators drop, supporting the narrow range around the current trajectory near 82. An atypical late-season resurgence or reporting delays could nudge the final figure outside 85–90, though such shifts remain unlikely given ongoing monitoring.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Mercado abierto: Jun 5, 2026, 3:37 PM ET
Volumen
$952Fecha de finalización
12 jun 2026Mercado abierto
Jun 5, 2026, 3:37 PM ETResolver
0x69c47De9D...This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Trader consensus heavily favors an 85–90 cumulative influenza-associated hospitalization rate per 100,000 population for Week 22 of the 2025–2026 season, reflecting CDC FluSurv-NET data showing activity has declined sharply since the winter peak. Weekly rates fell below 2 per 100,000 by March, with minimal new laboratory-confirmed admissions expected in late May and early June when influenza transmission typically reaches baseline levels. Historical patterns confirm that post-peak additions to cumulative totals remain small once surveillance indicators drop, supporting the narrow range around the current trajectory near 82. An atypical late-season resurgence or reporting delays could nudge the final figure outside 85–90, though such shifts remain unlikely given ongoing monitoring.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$952Fecha de finalización
12 jun 2026Mercado abierto
Jun 5, 2026, 3:37 PM ETResolver
0x69c47De9D...Trader consensus heavily favors an 85–90 cumulative influenza-associated hospitalization rate per 100,000 population for Week 22 of the 2025–2026 season, reflecting CDC FluSurv-NET data showing activity has declined sharply since the winter peak. Weekly rates fell below 2 per 100,000 by March, with minimal new laboratory-confirmed admissions expected in late May and early June when influenza transmission typically reaches baseline levels. Historical patterns confirm that post-peak additions to cumulative totals remain small once surveillance indicators drop, supporting the narrow range around the current trajectory near 82. An atypical late-season resurgence or reporting delays could nudge the final figure outside 85–90, though such shifts remain unlikely given ongoing monitoring.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes